Diagnostic anterior chamber paracentesis in uveitis: a safe procedure?

Differentiating between infectious and non-infectious uveitis is essential for proper patient care. While serum tests are commonly used, aqueous humour analysis provides more specific insights. Prior research has shown that diagnostic procedures on the eye can carry risks such as cataract formation or infection. However, the safety of anterior chamber paracentesis in uveitis patients remains unclear. No prior work had resolved whether diagnostic paracentesis could be reliably performed without significant complications. This uncertainty drove the need for a large-scale clinical evaluation. Existing studies lack detailed follow-up periods or sufficient sample sizes. The absence of long-term safety data creates a gap in clinical decision-making. This study aimed to address that gap by examining outcomes in a large patient cohort. The goal was to determine if the procedure is suitable for routine clinical use.

The study aimed to assess the safety of diagnostic anterior chamber paracentesis in patients with uveitis. Uveitis can have infectious or non-infectious origins, and accurate diagnosis is crucial for treatment planning. The researchers sought to determine if this procedure could be safely performed without causing significant complications. The specific problem addressed was the lack of robust safety data for this diagnostic method. Previous studies had limited follow-up or small sample sizes. This study aimed to provide comprehensive safety evidence. The motivation was to support clinical decisions by confirming the procedure's reliability. The researchers focused on complications such as cataract or infection.

The study used a retrospective design to analyze clinical records of 361 uveitis patients who underwent anterior chamber paracentesis. Data were collected from outpatient clinic visits and followed up for periods ranging from six months to over three years. The researchers examined the site of the paracentesis, anterior chamber depth, and presence of cells in the eye. Seventy-two patients were assessed 30 minutes post-procedure. The study focused on identifying complications like cataract or endophthalmitis. Clinical records were reviewed to track long-term outcomes. The analysis emphasized the occurrence of adverse events. The researchers compared pre- and post-procedure findings to assess safety.

No serious complications such as cataract, keratitis, or endophthalmitis were observed in any of the 361 patients. All patients had their anterior chamber depth restored within 30 minutes after the procedure. Five out of 72 patients showed a small hyphaema 30 minutes post-paracentesis. These included three AIDS patients with cytomegalovirus retinitis and two with herpes simplex virus-related uveitis. No long-term complications were reported during follow-up periods of up to three years. The procedure was performed in an outpatient setting, indicating minimal disruption to patient care. The study found no evidence of permanent damage or infection. The results suggest that the procedure is well-tolerated in most patients.

The study suggests that diagnostic anterior chamber paracentesis is a safe procedure when performed by an experienced ophthalmologist. The findings indicate that serious complications such as cataract or endophthalmitis do not occur frequently. The procedure appears suitable for routine clinical use in uveitis patients. The absence of long-term complications supports its safety profile. The observed hyphaema in five cases was minor and did not lead to lasting effects. The study confirms that the anterior chamber depth is restored quickly after the procedure. These results align with the authors' claim that the procedure is reliable in clinical practice. The findings support the use of paracentesis for accurate uveitis diagnosis.